United States Steel Statistics
Total Valuation
CannaPharmaRX has a market cap or net worth of 2.10 million. The enterprise value is 19.49 million.
| Market Cap | 2.10M |
| Enterprise Value | 19.49M |
Important Dates
The next estimated earnings date is Friday, August 15, 2025.
| Earnings Date | Aug 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CannaPharmaRX has 656.27 million shares outstanding. The number of shares has increased by 117.50% in one year.
| Current Share Class | 656.27M |
| Shares Outstanding | 656.27M |
| Shares Change (YoY) | +117.50% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 3.66% |
| Owned by Institutions (%) | n/a |
| Float | 607.90M |
Valuation Ratios
The trailing PE ratio is 2.01.
| PE Ratio | 2.01 |
| Forward PE | n/a |
| PS Ratio | 1.86 |
| PB Ratio | -0.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 17.42 |
| EV / Sales | 17.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | 0.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -17.72% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 20.46% |
| Revenue Per Employee | 43,447 |
| Profits Per Employee | 43,048 |
| Employee Count | 26 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 4.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.00% in the last 52 weeks. The beta is -1,575.46, so CannaPharmaRX's price volatility has been lower than the market average.
| Beta (5Y) | -1,575.46 |
| 52-Week Price Change | -78.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 28.28 |
| Average Volume (20 Days) | 271,009 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
In the last 12 months, CannaPharmaRX had revenue of 1.13 million and earned 1.12 million in profits. Earnings per share was 0.00.
| Revenue | 1.13M |
| Gross Profit | -2.74M |
| Operating Income | -3.20M |
| Pretax Income | 1.12M |
| Net Income | 1.12M |
| EBITDA | -3.10M |
| EBIT | -3.20M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 1,208 in cash and 16.76 million in debt, giving a net cash position of -16.76 million or -0.03 per share.
| Cash & Cash Equivalents | 1,208 |
| Total Debt | 16.76M |
| Net Cash | -16.76M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -20.51M |
| Book Value Per Share | -0.03 |
| Working Capital | -25.66M |
Cash Flow
| Operating Cash Flow | -1.75M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -242.80%, with operating and profit margins of -283.60% and 99.08%.
| Gross Margin | -242.80% |
| Operating Margin | -283.60% |
| Pretax Margin | 99.08% |
| Profit Margin | 99.08% |
| EBITDA Margin | -274.33% |
| EBIT Margin | -283.60% |
| FCF Margin | n/a |
Dividends & Yields
CannaPharmaRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -117.50% |
| Shareholder Yield | n/a |
| Earnings Yield | 53.30% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CannaPharmaRX has an Altman Z-Score of -16.16 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.16 |
| Piotroski F-Score | 4 |